Walleye Trading
JNP

Walleye Trading’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History

Walleye Trading’s Portfolio JNP Stock Details JNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-3,200
Closed -$15 – 5259
2017
Q1 		$15 Buy
3,200
+1,600
+100% +$8.08K ﹤0.01% 4238
2016
Q4 		$9K Sell
1,600
-800
-33% -$4.39K ﹤0.01% 4351
2016
Q3 		$13K Buy
2,400
+2,200
+1,100% +$14.5K ﹤0.01% 4349
2016
Q2 		$1K Buy
+200
New +$1.41K ﹤0.01% 5221
2016
Q1 		– Sell
-1,000
Closed -$10K – 6117
2015
Q4 		$10K Buy
+1,000
New +$11.6K ﹤0.01% 4750

Other funds holding JNP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
MERSOM
Municipal Employees' Retirement System of Michigan Lansing, Michigan $8.81B AUM 10.88% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
AG
Algert Global San Francisco, California $6.65B AUM 53.68% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Walleye Trading's JNP Position: Q2 2017 in Review

Walleye Trading sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q2 2017, closing a stake of 3,200 shares — an estimated $15 sold.

Walleye Trading first reported a position in JNP in Q4 2015 and held it in 5 quarters. The position peaked at $13K in Q3 2016. 33 funds tracked by Wall St. Rank hold JNP as of Q2 2017.

  • Walleye Trading reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q2 2017 after selling out during the quarter.
  • Walleye Trading sold 3,200 Juniper Pharmaceuticals, Inc. Common Stock shares in Q2 2017, an estimated $15.
  • Walleye Trading first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q4 2015 and held it in 5 quarters.
  • Walleye Trading's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $13K in Q3 2016.
  • 33 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q2 2017.

Based on Walleye Trading's 13F filing for Q2 2017, filed 14 Aug 2017.